N-of-I randomized controlled trials ('N-of-I trials'): Singularly useful in geriatric medicine

Age and Ageing

Volumn 31, Issue 4, 2002, Pages 227-232

  Price, James D ^a   Evans, John Grimley ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; GENERAL PRACTICE; GERIATRICS; HEALTH CARE COST; HEALTH STATUS; HUMAN; HYPOTHESIS; MEDICAL CARE; MEDICAL ETHICS; MEDICAL INFORMATION; MEDICAL RESEARCH; MEDICAL SERVICE; METHODOLOGY; OUTCOMES RESEARCH; PERCEPTION; PRESCRIPTION; PRIORITY JOURNAL; PUBLIC HEALTH; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STATISTICAL ANALYSIS; TIME; VARIANCE; VISUAL ANALOG SCALE; WELLBEING; AGING; ELDERLY CARE; REVIEW;

AGED; AGING; ETHICS, MEDICAL; HEALTH SERVICES FOR THE AGED; HUMANS; RANDOMIZED CONTROLLED TRIALS;

EID: 0036633940     PISSN: 00020729     EISSN: None     Source Type: Journal    
DOI: 10.1093/ageing/31.4.227     Document Type: Article

References (35)

1. Evidence-based and evidence-biased medicine
2. Prediction of benefit from carotid endarterectomy in individual patients: A risk-modelling study
3. Single subject designs for assessment of psychotropic drug effects in children
4. Determining optimal therapy - Randomized trials in individual patients
5. Research is needed into why such trials are not more widely used
6. Unjustified exclusion of elderly people from studies submitted to research ethics committee for approval: Descriptive study
7. Exclusion of elderly people from clinical research: A descriptive study of published reports
8. The health of the UK's elderly people
9. Opren scandal
10. Differences in valuation of functional status components among consumers and professionals in Europe and the United States
11. N of 1 randomized trials for investigating new drugs
12. An N-of-1 Randomized Controlled Trial ('N-of-1 trial') of donepezil in the treatment of non-progressive amnestic syndrome
13. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment
14. A clinician's guide for conducting randomized trials in individual patients
15. Randomized controlled trials in single patients (editorial)
16. Sequential medical trials
17. A new approach to the measurement of quality of life. The Patient-Generated Index
18. Individual quality of life in the healthy elderly
19. The Hopkins Verbal Learning Test: Development of a new memory test with six equivalent forms
20. Comparison of visual inspection and statistical analysis of single-subject data in rehabilitation research
21. Single-case studies. An introduction
22. Statistical issues in studies of individual response
23. The N-of-1 randomized controlled trial: Clinical usefulness. Our three-year experience
24. Statistical issues in drug development
25. Combining single patient (N-of-1) trials to estimate population treatment effects and to evaluate individual patient responses to treatment
26. Ethics of N-of-1 trials
27. Clinical usefulness of N-of-1 randomized controlled clinical trials in patients with nonreversible chronic airflow limitation
28. Clinical usefulness of amitriptyline in fibromyalgia: The results of 23 N-of-1 randomized controlled trials
29. N of 1 trials comparing a non-steroidal anti-inflammatory drug with paracetamol in osteoarthritis
30. Preliminary experiences with a single-patient trials service in general practice
31. Feasibility study of N-of-1 trials with blood pressure self-monitoring in hypertension
32. Randomised study of n of 1 trials versus standard practice
33. Toward individualized evidence-based medicine: Five 'N of 1' trials of methylphenidate in geriatric patients
34. Recombinant DNase in cystic fibrosis: A protocol for targeted introduction through n-of-1 trials
35. Decision analysis and the implementation of evidence-based medicine